Lipella pharmaceuticals announces publication in cureus on non-steroid treatment of oral lichen planus

Peer-reviewed article highlights potential treatment for olp with focus on localized drug delivery pittsburgh, dec. 03, 2024 – prism mediawire – lipella pharmaceuticals inc. (nasdaq: lipo), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, today announced the publication of a peer-reviewed paper in cureus.
LIPO Ratings Summary
LIPO Quant Ranking